Baseline characteristics of the 33 trials included in the meta-analysis (n = 6882).
收藏数据链接：
官方服务：
资源简介：
Abbreviations: PFS, progression-free survival; OS, overall survival; RCC, renal cell cancer; NSCLC, non-small-cell lung carcinoma; SCLC, small-cell lung cancer; CRC, Colorectal cancer; STS, soft tissue sarcoma; Bev, bevacizumab; GEM, gemcitabine; PTX, paclitaxel; NR, not reported; N/A, not applicable.
创建时间：
2015-12-02
